The Journal of Managed Care & Specialty Pharmacy

Subscribe to RSS - The Journal of Managed Care & Specialty Pharmacy

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study

The study concludes that antiviral treatment with sofosbuvir and/or simeprevir was requested for a relatively small proportion of Hepatitis C-infected members of MassHealth, the Massachusetts Medicaid program, with nearly all approved. Prescriber prioritization or patient barriers to care, rather than prior authorization, determined access to treatment. Support may be needed to ensure patients with SUD benefit from advances in HCV treatment.